Synrise

森瑞斯

Synrise

Biotech/Healthcare

Founded in 2019, SynRise focuses on synthetic biology R&D and innovative applications across pharmaceuticals, chemicals, agriculture, consumer products, and other sectors, with the aim of contributing to China’s carbon-neutrality goals. The company has achieved multiple breakthroughs in synthetic…

Latest round: Series A (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-03-01